Mirador Capital Partners »

Sarepta Therapeutics shares owned by Mirador Capital Partners

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by Mirador Capital Partners from 13F filings

Historical chart of Mirador Capital Partners investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by Mirador Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0M 140k 21.52

More positions owned by Mirador Capital Partners

Invesco Exch Trd Slf Idx Invsco Blsh 26 (BSJQ)
Invesco Exch Trd Slf Idx Buletshs 2027 (BSJR)
Alphabet Cap Stk Cl C (GOOG)
Apple (AAPL)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl A (GOOGL)
Blackstone Group Inc Com Cl A (BX)
Chevron Corporation (CVX)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Abbvie (ABBV)
Cytokinetics Com New (CYTK)
Kkr & Co (KKR)

View all positions for Mirador Capital Partners

Top funds holding Sarepta Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Susquehanna International
Erste Asset Management GmbH
Standard Life Aberdeen
Two Sigma Investments
D. E. Shaw & Co
UBS Group
First Trust Advisors
Two Sigma Advisers
Geode Capital Management
LMR Partners
Citadel Advisors
AQR Capital Management

View all funds holding Sarepta Therapeutics